Aditxt (ADTX) Equity Ratio (2019 - 2026)

Aditxt (ADTX) recorded quarterly Equity Ratio of 2.53 in Q1 2026, down 844.71% quarter-over-quarter from 0.34 in Q4 2025, and down 561.34% on a YoY basis from 0.55 in Q1 2025.

Aditxt (ADTX) Equity Ratio (2019 - 2026) Analysis & Trends

Aditxt's Equity Ratio history runs 8 years deep, the most recent figure standing at 2.53 for Q1 2026.

  • In Q1 2026, Equity Ratio fell 561.34% year-over-year to 2.53; the TTM figure through Mar 2026 stood at 2.53 (down 561.34% YoY), while the FY2025 annual figure was 0.34, up 900.32% from the prior year.
  • Equity Ratio was 2.53 for Q1 2026 at Aditxt, down from 0.34 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.66 in Q3 2022 to a low of 2.53 in Q1 2026.
  • Historically, Equity Ratio has averaged 0.01 across 5 years, with a median of 0.22 in 2024.
  • The sharpest annual moves came in 2024 and 2026: Equity Ratio soared 3821.27% in 2024, then tumbled 561.34% in 2026.
  • A 5-year view of Equity Ratio shows it stood at 0.48 in 2022, then declined by 25.78% to 0.36 in 2023, then slumped by 90.57% to 0.03 in 2024, then surged by 900.32% to 0.34 in 2025, then plunged by 844.71% to 2.53 in 2026.
  • The last three Equity Ratio figures came in at 2.53 (Q1 2026), 0.34 (Q4 2025), and 0.66 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 191.07
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 0.98
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 0.04
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.58
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 0.42
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 0.73
9 Abivax 91.96 Bn 91.96 Bn - 0.79
10 Aditxt 2,485.68 -2.16 Mn 2,868.00 -2.53

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.53
Dec 31, 2025 0.34
Sep 30, 2025 -0.66
Jun 30, 2025 0.41
Mar 31, 2025 0.55
Dec 31, 2024 0.03
Sep 30, 2024 0.15
Jun 30, 2024 0.22
Mar 31, 2024 0.35
Dec 31, 2023 0.36
Sep 30, 2023 -0.51
Jun 30, 2023 -0.53
Mar 31, 2023 0.01
Dec 31, 2022 0.48
Sep 30, 2022 0.66
Jun 30, 2022 0.13
Mar 31, 2022 0.40
Dec 31, 2021 0.61
Sep 30, 2021 0.66
Jun 30, 2021 0.37